Duchenne muscular dystrophy natural history, complications and prognosis: Difference between revisions
(Created page with "__NOTOC__ {{Duchenne muscular dystrophy}} {{CMG}}; {{AE}} {{Fs}} ==Overview== If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation...") |
No edit summary |
||
Line 17: | Line 17: | ||
===Natural History=== | ===Natural History=== | ||
*The symptoms of | *The symptoms of Duchenne muscular dystrophy usually develop in the first decade of life, and start with symptoms such as muscle weakness and gait abnormalities. | ||
*If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3]. | *If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3]. | ||
Line 28: | Line 27: | ||
===Prognosis=== | ===Prognosis=== | ||
*Prognosis is generally | *Prognosis is generally poor, and the mortality rate of patients with Duchenne muscular dystrophy is approximately 100%.<ref name="Visservan den Berg-Vos2007">{{cite journal|last1=Visser|first1=Jeldican|last2=van den Berg-Vos|first2=Renske M.|last3=Franssen|first3=Hessel|last4=van den Berg|first4=Leonard H.|last5=Wokke|first5=John H.|last6=Vianney de Jong|first6=J. M.|last7=Holman|first7=Rebecca|last8=de Haan|first8=Rob J.|last9=de Visser|first9=Marianne|title=Disease Course and Prognostic Factors of Progressive Muscular Atrophy|journal=Archives of Neurology|volume=64|issue=4|year=2007|pages=522|issn=0003-9942|doi=10.1001/archneur.64.4.522}}</ref> | ||
*The presence of low vital capacity or a sharp decline of vital capacity is associated with a particularly poor prognosis among patients with Duchenne muscular dystrophy. | |||
*The presence of | |||
==References== | ==References== |
Revision as of 14:41, 29 April 2019
Duchenne muscular dystrophy Microchapters |
Differentiating Duchenne muscular dystrophy from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Duchenne muscular dystrophy natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Duchenne muscular dystrophy natural history, complications and prognosis |
FDA on Duchenne muscular dystrophy natural history, complications and prognosis |
CDC on Duchenne muscular dystrophy natural history, complications and prognosis |
Duchenne muscular dystrophy natural history, complications and prognosis in the news |
Blogs on Duchenne muscular dystrophy natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.
Overview
If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
OR
Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
OR
Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
Natural History, Complications, and Prognosis
Natural History
- The symptoms of Duchenne muscular dystrophy usually develop in the first decade of life, and start with symptoms such as muscle weakness and gait abnormalities.
- If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
Complications
- Common complications of [disease name] include:
- [Complication 1]
- [Complication 2]
- [Complication 3]
Prognosis
- Prognosis is generally poor, and the mortality rate of patients with Duchenne muscular dystrophy is approximately 100%.[1]
- The presence of low vital capacity or a sharp decline of vital capacity is associated with a particularly poor prognosis among patients with Duchenne muscular dystrophy.
References
- ↑ Visser, Jeldican; van den Berg-Vos, Renske M.; Franssen, Hessel; van den Berg, Leonard H.; Wokke, John H.; Vianney de Jong, J. M.; Holman, Rebecca; de Haan, Rob J.; de Visser, Marianne (2007). "Disease Course and Prognostic Factors of Progressive Muscular Atrophy". Archives of Neurology. 64 (4): 522. doi:10.1001/archneur.64.4.522. ISSN 0003-9942.